Risk Assessment of PSA Recurrent Prostate Cancer
Release Date:
As part of the 2024 Prostate Cancer Patient Conference, Dr. Mack Roach discusses the phenomenon of “biochemical recurrence” and approaches to risk assessment, following treatments for localized prostate cancer.
Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39761]
Risk Assessment of PSA Recurrent Prostate Cancer